Abstract
Recently, an interesting study entitled “Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19” was published in Digestive and Liver Disease [1]. In this retrospective cohort study, the authors explored the relationship between liver fibrosis and poor prognosis in patients with coronavirus disease (COVID-19). After controlling for potential confounding factors, the authors found that the presence of liver fibrosis was associated with higher mechanical ventilation, acute kidney injury (AKI), and mortality.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
